The blood coagulation factor market is experiencing consistent growth due to the increasing prevalence of bleeding disorders, advancements in recombinant therapies, and rising awareness regarding early diagnosis and treatment. Blood coagulation factors are essential therapeutic products used to manage inherited and acquired coagulation disorders, particularly hemophilia and other rare bleeding...

Hypoprothrombinemia Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the Hypoprothrombinemia Treatment Market  CAGR Value The global hypoprothrombinemia treatment market size was valued at USD 1.08 billion in 2025 and is expected to reach USD 1.53 billion by 2033, at a CAGR of 4.50% during the...